IFN-alpha/beta R1

IFN-alpha/beta R1

IFN-alpha/beta R1 Molekülinformation

Molecule Name
Interferon-alpha/beta receptor alpha chain
Molekülalias
IFNAR1,IFNAR,CRF2-1,IFN-R-1,IFNAR-1
Drug Development Progress
Anzahl der klinischen Arzneimittel0
Anzahl der inverkehr gebrachten Arzneimittel5
Höchste Forschungs- und EntwicklungsphaseApproved
Target-Alias
IFNBR,IFN-Alpha-REC,Beta-Type Antiviral Protein,IFNAR,Cytokine Receptor Class-II Member 1,Interferon Receptor 1,IFNAR1,Interferon Alpha/Beta Receptor 1,Interferon Alpha And Beta Receptor Subunit 1,Type I Interferon Receptor 1,Interferon (Alpha, Beta And Omega) Receptor 1,Alpha-Type Antiviral Protein,IFN-Alpha/Beta Receptor 1,AVP,Interferon-Beta Receptor 1,IFRC,IFN-R-1,CRF2-1,Cytokine Receptor Family 2 Member 1,Interferon-Alpha/Beta Receptor Alpha Chain
Molekülhintergrund
Interferon alpha/beta receptor 1 ( IFNAR1) is also known as Cytokine receptor class-II member 1, Cytokine receptor family 2 member 1 (CRF2-1), Type I interferon receptor 1, IFNAR, which belongs to the type II cytokine receptor family. IFNAR1 /IFNAR contains four fibronectin type-III domains. IFNAR1 associates with IFNAR2 to form the type I interferon receptor. IFNAR1 is receptor for interferons alpha and beta. IFNAR1 can transduce IFNB signals without the help of IFNAR2, and not activating the Jak-STAT pathway.

IFN-alpha/beta R1 Produktliste

Species
  • Human(7)
  • Cynomolgus(1)
  • Mouse(1)
Tag
  • His Tag(5)
  • His Tag & Avi Tag(3)
  • Fc Tag(1)
Host
  • HEK293(9)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(3)
Grade
  • RUO(9)
Low Endotoxin
  • Yes(2)
  • No(7)
You Have Viewed 1-9 Of 9 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Interferon beta (Toray/Daiichi Sankyo)DL-8234ApprovedToray Industries IncFeronJapanMedulloblastoma; Melanoma; Hepatitis C; Astrocytoma; Glioblastoma; Hepatitis Bnull1985-04-01
Astrocytoma; Glioblastoma; Hepatitis B; Hepatitis C; Medulloblastoma; Melanoma
Details
Recombinant human interferon alfa-2b (Harbin Pharmaceutical Group Bioengineering)ApprovedHarbin Pharmaceutical Group Holding Co Ltd里亚美, 利分能Mainland ChinaHepatitis, Viral, Human; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Condylomata Acuminata; Varicella Zoster Virus InfectionHarbin Pharmaceutical Group Pharmaceutical Co Ltd1996-01-01
Condylomata Acuminata; Hepatitis, Viral, Human; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Varicella Zoster Virus Infection
Details
Recombinant human interferon α2b biosimilar (Harbin High-Tech White Swan Pharmaceutical)ApprovedHarbin High-Tech Group Baitian'Er Pharmaceutical Co LtdFu Li Sheng
Condylomata Acuminata; Hepatitis; Herpes Zoster; Leukemia, Hairy Cell; Leukemia, Myeloid, Chronic-Phase; Lymphoma, Non-Hodgkin; Multiple Myeloma
Details
AnifrolumabMEDI-546; MDX-1333ApprovedMedarex Inc, Medimmune LlcSAPHNELOUnited StatesLupus Erythematosus, SystemicAstrazeneca Ab2021-07-30
Atherosclerosis; Autoimmune Diseases; Cardiovascular Diseases; Dermatomyositis; Hidradenitis; Hidradenitis Suppurativa; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Nephritis; Myositis; Polymyositis; Scleroderma, Systemic; Sjogren's Syndrome; Vitiligo
Details
Recombinant human interferon α2b biosimilar (Zhejiang Hansheng)ApprovedZhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma莱福隆Mainland ChinaVirus Diseases; NeoplasmsZhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma1999-01-01
Neoplasms; Virus Diseases
Details
Customer Reviews